CSPC Innovation Pharmaceutical Co Ltd Class A - Asset Resilience Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has an Asset Resilience Ratio of 5.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 300765 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. See net asset quality index of CSPC Innovation Pharmaceutical Co Ltd Cl to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down CSPC Innovation Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CSPC Innovation Pharmaceutical Co Ltd Cl market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥350.30 Million | 5.64% |
| Total Liquid Assets | CN¥350.30 Million | 5.64% |
Asset Resilience Insights
- Limited Liquidity: CSPC Innovation Pharmaceutical Co Ltd Class A maintains only 5.64% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CSPC Innovation Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio
Compare CSPC Innovation Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Nestle India Limited
NSE:NESTLEIND |
Packaged Foods | 1.07% |
|
Inner Mongolia Yili Industrial Group Co Ltd
SHG:600887 |
Packaged Foods | 0.19% |
|
Saputo Inc
TO:SAP |
Packaged Foods | 3.36% |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895 |
Packaged Foods | 2.23% |
|
Orkla ASA
OL:ORK |
Packaged Foods | 4.19% |
|
Hanil Feed Co. Ltd
KQ:005860 |
Packaged Foods | 7.00% |
|
Lotus Bakeries
BR:LOTB |
Packaged Foods | 2.28% |
|
The a2 Milk Company Ltd
AU:A2M |
Packaged Foods | 24.93% |
Annual Asset Resilience Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2019–2025)
The table below shows the annual Asset Resilience Ratio data for CSPC Innovation Pharmaceutical Co Ltd Class A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.14% | CN¥385.39 Million ≈ $56.39 Million |
CN¥6.28 Billion ≈ $918.42 Million |
-1.67pp |
| 2024-12-31 | 7.81% | CN¥470.09 Million ≈ $68.79 Million |
CN¥6.02 Billion ≈ $881.22 Million |
-3.25pp |
| 2021-12-31 | 11.06% | CN¥413.59 Million ≈ $60.52 Million |
CN¥3.74 Billion ≈ $547.46 Million |
+0.17pp |
| 2020-12-31 | 10.89% | CN¥321.94 Million ≈ $47.11 Million |
CN¥2.96 Billion ≈ $432.64 Million |
-22.77pp |
| 2019-12-31 | 33.66% | CN¥960.09 Million ≈ $140.49 Million |
CN¥2.85 Billion ≈ $417.39 Million |
-- |
About CSPC Innovation Pharmaceutical Co Ltd Class A
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food product… Read more